Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 420,512 | 428,266 | 220,805 | 242,455 | 140,039 |
| Receivables | 3,723 | 2,740 | 2,686 | 2,640 | 2,910 |
| TOTAL | $431,312 | $439,756 | $231,298 | $253,562 | $149,634 |
| Non-Current Assets | |||||
| PPE Net | 3,097 | 3,025 | 2,890 | 2,961 | 2,845 |
| Intangibles | 4,168 | 4,296 | 3,950 | 4,108 | 3,844 |
| Other Non-Current Assets | 1,330 | 1,367 | 331 | 334 | 306 |
| TOTAL | $8,595 | $8,688 | $7,172 | $7,402 | $6,995 |
| Total Assets | $439,907 | $448,444 | $238,470 | $260,964 | $156,629 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 43,666 | 21,404 | 26,865 | 23,025 | 17,088 |
| TOTAL | $43,696 | $21,404 | $26,865 | $23,377 | $17,527 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 111 | 103 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $43,696 | $21,404 | $26,865 | $23,377 | $17,527 |
| Shareholders' Equity | |||||
| Common Shares | 6,701 | 6,855 | 5,614 | 5,740 | 4,801 |
| Retained earnings | -390,412 | -374,396 | -297,506 | 208,377 | 114,436 |
| Other shareholders' equity | 37,773 | 33,740 | 25,747 | 23,470 | 19,865 |
| TOTAL | $396,212 | $427,040 | $211,605 | $237,587 | $139,102 |
| Total Liabilities And Equity | $439,907 | $448,444 | $238,470 | $260,964 | $156,629 |